视神经鞘直径超声与卒中结局
单中心前瞻性观察研究纳入86例疑似卒中(缺血或出血性)患者,入院时及入院头2天内测量双侧视神经鞘直径,结局为院内生存、脑功能分类及3个月和6个月改良Rankin量表。左右眼测量无差异(p=0.467和p=0.903),纵横向测量也无差异(横向p=0.163、纵向p=0.270)。存活与院内死亡患者的平均视神经鞘直径在缺血性卒中(0.53 vs 0.58 cm;p=0.009)和出血性卒中(0.57 vs 0.62 cm;p=0.019)中均有差异。视神经鞘直径增加与6个月改良Rankin量表3-6分的不良功能结局相关(r=0.44;p<0.0001)。作者认为视神经鞘直径可能作为院内死亡和功能结局的无创标志物,需进一步多中心前瞻性试验验证。
要点
- 缺血性卒中院内死亡者平均视神经鞘直径0.58 cm,存活者0.53 cm(p=0.009)。
- 出血性卒中院内死亡者平均视神经鞘直径0.62 cm,存活者0.57 cm(p=0.019)。
- 视神经鞘直径每增加0.1 cm,缺血性卒中院内死亡OR 4.2(95%CI 1.32-13.64;p=0.015)。
- 视神经鞘直径每增加0.1 cm,缺血或出血性卒中院内死亡OR 6.2(95%CI 1.160-33.382;p=0.033)。
- 视神经鞘直径增加与6个月改良Rankin量表3-6分不良功能结局相关(r=0.44;p<0.0001)。
适用人群与场景
- 疑似卒中的急诊科和ICU患者,最终纳入缺血性或出血性卒中86例。
- 平均年龄67.2岁(±15岁),54.7%为男性。
研究设计与关键结果
- 单中心前瞻性观察研究,纳入86例缺血性或出血性卒中患者,入院时及入院头2天内测量双侧视神经鞘直径,无干预。
- 结局为院内生存、脑功能分类及3个月和6个月改良Rankin量表;分析采用描述性统计、配对t检验、卡方检验。
- 左右眼测量无差异(p=0.467和p=0.903),纵向与横向测量无差异(横向p=0.163、纵向p=0.270)。
- 存活与院内死亡患者的平均视神经鞘直径在缺血性卒中为0.53 vs 0.58 cm(p=0.009),在出血性卒中为0.57 vs 0.62 cm(p=0.019)。
- 视神经鞘直径每增加0.1 cm,缺血性卒中院内死亡OR 4.2(95%CI 1.32-13.64;p=0.015),缺血或出血性卒中院内死亡OR 6.2(95%CI 1.160-33.382;p=0.033)。
- 视神经鞘直径增加与6个月改良Rankin量表3-6分不良功能结局相关(r=0.44;p<0.0001)。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察研究。
- 作者结论:视神经鞘直径升高与院内死亡增加和6个月不良功能结局相关;视神经鞘直径可能作为院内死亡和功能结局的无创标志物;需进一步多中心前瞻性试验评估和治疗缺血性和出血性卒中的视神经鞘直径。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为视神经鞘直径可能作为缺血性和出血性卒中患者院内死亡和6个月功能结局的无创标志物。
- 作者认为需进一步开展多中心前瞻性试验来评估和治疗缺血性和出血性卒中的视神经鞘直径。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: We aimed at utilizing ocular ultrasound to determine its utility in predicting outcomes among stroke patients.
DESIGN: Single-center prospective observational study.
SETTING: Emergency department and ICUs.
PATIENTS: Patients suspected of stroke.
INTERVENTIONS: None.
MEASURES AND MAIN RESULTS: Bilateral optic nerve sheath diameter was measured on arrival and within the first 2 days of admission. Outcomes were inpatient survival, Cerebral Performance Category, and modified Rankin Scale at 3 and 6 months. Analysis was conducted using descriptive statistics, paired t test, chi-square test. Eighty-six patients were enrolled with ischemic or hemorrhagic stroke. Mean age was 67.2 years (± 15 yr), and 54.7% of patients were male. There was no difference between left and right eye measurements (p = 0.467 and p = 0.903, respectively) or between longitudinal and transverse measurements (transverse p = 0.163 and longitudinal p = 0.270). Mean optic nerve sheath diameter differed in patients who survived versus died prior to discharge in both ischemic (0.53 vs 0.58 cm; p = 0.009) or hemorrhagic stroke (0.57 vs 0.62 cm; p = 0.019). For every 0.1 cm increase in optic nerve sheath diameter, odds ratio for death were 4.2 among ischemic stroke (95% CI, 1.32-13.64; p = 0.015), and odds ratio 6.2 among ischemic or hemorrhagic patients (95% CI, 1.160-33.382; p = 0.033). Increased optic nerve sheath diameter correlated (r = 0.44; p < 0.0001) with poor functional outcomes measured as modified Rankin Scale scores of 3-6 at 6 months.
CONCLUSIONS: Elevations in optic nerve sheath diameter were associated with increased inhospital mortality and poor functional outcome at 6 months. Optic nerve sheath diameter may serve as a noninvasive marker of inhospital mortality and functional outcome. Further multicenter prospective trials for evaluating and treating optic nerve sheath diameter in ischemic and hemorrhagic strokes are warranted.
参考来源
- Patel R, Chowdhury MAB, Gul S, et al. Ultrasound of Optic Nerve Sheath Diameter and Stroke Outcomes. Crit Care Explor. 2021. PMID: 34841250. doi:10.1097/CCE.0000000000000565
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。